<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>75</volume><submitter>Sun YJ</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Triple-negative breast cancer (TNBC) has a high mortality rate and limited treatment options. Tetrahydrocurcumin (THC), a major metabolite of curcumin, has potential antitumor activities. However, the antitumor effects and mechanism of THC in TNBC remain elusive.&lt;h4>Objectives&lt;/h4>To investigate the mechanism of THC in combating TNBC by targeting TRIP13 to disrupt the interaction of the TRIP13/USP7/c-FLIP complex and mediate c-FLIP ubiquitination both in vitro and in vivo.&lt;h4>Methods&lt;/h4>Apoptosis was measured by TUNEL and flow cytometry. Click chemistry-based target fishing, CETSA, DARTS, and SPR were used to identify direct target of THC. Protein interactions was examined using co-immunoprecipitation. The role of USP7 in THC-mediated c-FLIP ubiquitination was evaluat</pubmed_abstract><journal>Journal of advanced research</journal><pagination>591-605</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12789769</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Tetrahydrocurcumin targets TRIP13 inhibiting the interaction of TRIP13/USP7/c-FLIP to mediate c-FLIP ubiquitination in triple-negative breast cancer.</pubmed_title><pmcid>PMC12789769</pmcid><pubmed_authors>Sun YJ</pubmed_authors><pubmed_authors>Sun XH</pubmed_authors><pubmed_authors>Qiu F</pubmed_authors><pubmed_authors>Zhao CY</pubmed_authors><pubmed_authors>Zhang Q</pubmed_authors><pubmed_authors>Shang ZB</pubmed_authors><pubmed_authors>Cao ZY</pubmed_authors><pubmed_authors>Gao XM</pubmed_authors><pubmed_authors>Cao SJ</pubmed_authors><pubmed_authors>Zhang JC</pubmed_authors><pubmed_authors>Zhang QJ</pubmed_authors><pubmed_authors>Kang N</pubmed_authors><pubmed_authors>Zhang BY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tetrahydrocurcumin targets TRIP13 inhibiting the interaction of TRIP13/USP7/c-FLIP to mediate c-FLIP ubiquitination in triple-negative breast cancer.</name><description>&lt;h4>Introduction&lt;/h4>Triple-negative breast cancer (TNBC) has a high mortality rate and limited treatment options. Tetrahydrocurcumin (THC), a major metabolite of curcumin, has potential antitumor activities. However, the antitumor effects and mechanism of THC in TNBC remain elusive.&lt;h4>Objectives&lt;/h4>To investigate the mechanism of THC in combating TNBC by targeting TRIP13 to disrupt the interaction of the TRIP13/USP7/c-FLIP complex and mediate c-FLIP ubiquitination both in vitro and in vivo.&lt;h4>Methods&lt;/h4>Apoptosis was measured by TUNEL and flow cytometry. Click chemistry-based target fishing, CETSA, DARTS, and SPR were used to identify direct target of THC. Protein interactions was examined using co-immunoprecipitation. The role of USP7 in THC-mediated c-FLIP ubiquitination was evaluat</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-06T13:12:09.176Z</modification><creation>2026-05-30T03:11:40.744Z</creation></dates><accession>S-EPMC12789769</accession><cross_references><pubmed>39505147</pubmed><doi>10.1016/j.jare.2024.11.004</doi></cross_references></HashMap>